| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA687021 | F | Tested for activating effect of hepatitis C virus (HCV) in presence of ATP adjusted to 105 uM and 4.7 pM of DNA substrate | Hepacivirus hominis | 3 | organism-based format | Scientific Literature | ||
| 2. | ALA687022 | F | Tested for inhibition against 1.05 nM ATPase activity of hepatitis C virus (HCV) in presence of ATP adjusted to 1*10e-5 of Km of enzyme | Hepacivirus hominis | 2 | organism-based format | Scientific Literature | ||
| 3. | ALA687023 | F | Tested for inhibition against Helicase activity of hepatitis C virus (HCV) in presence of ATP adjusted to 105 uM and 4.7 pM of DNA substrate | Hepacivirus hominis | 10 | organism-based format | Scientific Literature | ||
| 4. | ALA687024 | F | Tested for inhibition against Helicase activity of hepatitis C virus (HCV) in presence of ATP adjusted to 105 uM and 4.7 pM of RNA duplex substrate | Hepacivirus hominis | 6 | organism-based format | Scientific Literature | ||
| 5. | ALA687025 | F | Tested for inhibition against 1.05 nM ATPase activity of hepatitis C virus (HCV) in presence of ATP adjusted to 1*10e-4 of Km of enzyme | Hepacivirus hominis | 2 | organism-based format | Scientific Literature | ||
| 6. | ALA691890 | F | Compound was evaluated for inhibition HCV NS5B-mediated RNA synthesis; Substrate | Hepacivirus hominis | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA872934 | F | Compound was evaluated for inhibition HCV NS5B-mediated RNA synthesis; nd denotes not determined | Hepacivirus hominis | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA691891 | F | Activity of compound against hepatitis C virus was determined; IA means inactive | Hepacivirus hominis | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA691892 | F | Compound was evaluated against hepatitis C virus; IA means inactive | Hepacivirus hominis | 4 | organism-based format | Scientific Literature | ||
| 10. | ALA691893 | F | Tested for inhibition of HCV RNA replication in a cell-basedassay; No significant inhibition | Hepacivirus hominis | 13 | organism-based format | Scientific Literature | ||
| 11. | ALA691894 | F | Inhibitory activity against hepatitis C virus protease enzyme(HCV) by using ELISA replicon assay | Hepacivirus hominis | 5 | organism-based format | Scientific Literature | ||
| 12. | ALA691895 | F | Inhibitory activity against hepatitis C virus protease enzyme(HCV) by using ELISA replicon assay; Not tested | Hepacivirus hominis | 3 | organism-based format | Scientific Literature | ||
| 13. | ALA697821 | F | Inhibitory activity against hepatitis C virus protease enzyme(HCV) NS3/4A | Hepacivirus hominis | 8 | organism-based format | Scientific Literature | ||
| 14. | ALA697823 | F | Inhibitory activity against HCV RNA replication | Hepacivirus hominis | 4 | organism-based format | Scientific Literature | ||
| 15. | ALA751822 | F | Inhibition of hepatitis C virus in a cell based HCV replicon assay. | Hepacivirus hominis | 23 | organism-based format | Scientific Literature | ||
| 16. | ALA840005 | F | Cytotoxic concentration against hepatitis C virus | Hepacivirus hominis | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA877114 | F | Effective concentration to inhibit RNA replication in hepatitis C virus | Hepacivirus hominis | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA834278 | F | Selectivity index as the ratio of CC50 and EC50 | Hepacivirus hominis | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA837238 | F | Cytotoxic concentration against hepatitis C virus | Hepacivirus hominis | 9 | organism-based format | Scientific Literature | ||
| 20. | ALA825117 | F | Cytotoxic concentration against Hepatitis C virus replication using sub-genomic replicon assay | Hepacivirus hominis | 5 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!